Metabolic Psychiatry Labs, Inc. (MPL) has secured $1.5 million in investment capital from investors. This funding round will significantly bolster MPL's mission to transform psychiatric care by pioneering a new approach to mental health that targets metabolic roots. Founded by Dr. Shebani Sethi, a distinguished metabolic psychiatry physician scientist from Stanford, MPL operates as a clinical research and innovation lab dedicated to advancing this specialized field.
MPL delivers care through remote care technology, advancing the field of Metabolic Psychiatry through translational science, clinical trials, and the development of digital tools. Its core areas of focus include ketogenic dietary therapies, metabolic biomarker discovery, and digital interventions for conditions such as depression, bipolar disorder, treatment-resistant psychosis, and obesity. The company is building a patient and provider-facing application to make metabolic therapies accessible.
This capital infusion is significant for MPL as it continues to develop its digital health platform and expand its research initiatives. The funds are expected to accelerate the development of tools that empower both patients and providers, bringing evidence-based metabolic therapies directly to those who need them through accessible technology. The investment underscores a growing interest in innovative, science-backed approaches to mental health care.
With this new funding, Metabolic Psychiatry Labs, Inc. is positioned to further its growth plans, combining scientific precision, compassionate care, and accessible technology to redefine psychiatric treatment paradigms. The company aims to broaden its impact and continue its work in integrating metabolic health into mental health care.
